Testing Is Not an Attack on the Trade

Testing Is Not an Attack on the Trade
Testing Is Not an Attack on the Trade

Testing is not an attack on the trade. It is how the trade earns the right to keep selling.

The latest University of California, Davis work on avocado oil in packaged foods should be welcomed, not dismissed. Full disclosure, we have done research here and I know many excellent academics/scientists at this institution.

Selina Wang PhD and her colleagues compared fatty-acid and sterol profiles against published reference ranges. They also checked whether frying and emulsification could explain the gaps. Most avocado-oil–labeled products did not match those ranges. Olive-oil–labeled products, run the same way, mostly did.

If I were in this oil business, I would get on a call with UC Davis and Dr. Wang the next day to go through the results.

Where there is no agreed standard of identity, a premium claim becomes a story — or an SEO/AEO play. Stories and customer acquisition tactics do not protect the shopper. They do not protect the manufacturer who paid for the real input. They do not protect the buyer who has to trust a supplier COA.

Where it was made, and how it was made, should be knowable. There is massive movement towards efficacy in the consumer packaged goods business.

If companies believe the method is wrong, publish a better one. If the range is too tight for natural variation, put the data on the table. If refining changes the fingerprint, run the before-and-after study the authors said is still needed.

Treat consumer trust with more care. New SKUs and new traffic should rest on peer-reviewed, fact-based measurements, not on what ranks.

That is as true for “avocado oil” as it is for acidity, caffeine, “pure,” and every other claim that commands a higher price.

Puroast Coffee has spent more than $8 million over two decades on lab testing, university research, other wellness research, and patent prosecution because the alternative was a claim nobody could check.

Trade associations, retailers, and brands should put this paper on an open forum.

Invite UC Davis. Invite Codex, Invite health care professionals (all types) and AOCS chemists. Invite the suppliers.

Let a LinkedIn Live, YouTube, or other forums have an open discussion do what a closed memo will not.

Fact-based claims will be the norm. Placebo marketing is ending.

0 comments

Leave a comment

Please note, comments must be approved before they are published